Posts Tagged ‘broking-house’

Emkay recommends `Accumulate ` on Tata Steel

Emkay has recommended `Accumulate` on Tata Steel with a price target of Rs 684 as against the current market price (CMP) of Rs 621 in its report dated Apr. 01, 2011

Emkay recommends `Hold ` on Dishman Pharma

Emkay has recommended `Hold` on Dishman Pharma with a price target of Rs 118 as against the current market price (CMP) of Rs 102 in its report dated Apr. 1, 2011. The broking house gave the following rationale: > We believe Dishman`s under performance to continue for some more time until clarity emerges in CRAMS business.

Emkay recommends `Sell ` on Idea Cellular

Emkay has recommended `Sell` on Idea Cellular with a price target of Rs 60 as against the current market price (CMP) of Rs 68 in its report dated Apr. 01, 2011. The broking house gave the following rationale: > Strong rebound in revenue growth supported by significant improvement in KPI`s has led to improvement in revenues in last quarter.

Emkay recommends `Reduce ` on JSW Energy

Emkay has recommended `Reduce ` on JSW Energy with a price target of Rs 78 as against the current market price (CMP) of Rs 72 in its report dated Apr. 01, 2011. The broking house gave the following rationale: > One of the most experienced IPPs with execution of it`s under construction phase at advance stage; to add 2,010MW in FY10-FY12E.

Emkay recommends `Buy` on L&T

Emkay has recommended `Buy ` on Larsen & Toubro (L&T) with a price target of Rs 2,015 as against the current market price (CMP) of Rs 1,653 in its report dated Apr. 1, 2011. The broking house gave the following rationale: > Strong presence in structural sectors (Utilities and Construction exposure at 69%) to continue to augur well during FY10-12E.

Emkay recommends `Accumulate` on Cadila Healthcare

Emkay has recommended ` Accumulate ` on Cadila Healthcare with a price target of Rs 847 as against the current market price (CMP) of Rs 791 in its report dated Apr.1, 2011. The broking house gave the following rationale: > Cadlila Healthcare emerges our top pick given its strong growth prospects (30% earnings CAGR over FY10- 13E), wide geographical reach and foray into difficult to manufacture generics such as transdermal patches, biosimilar and vaccines

Emkay recommends `Buy` on IRB Infra

Emkay has recommended ` Buy ` on IRB Infrastructure Developers with a price target of Rs 280 as against the current market price (CMP) of Rs 212 in its report dated Apr.1, 2011. The broking house gave the following rationale: > India Premier road asset, with commendable track record Bagged 7 NHAI projects over last 4 years with market share of 7% port folio set to grow at 25% CAGR over FY08-14E Asset base to grow at 38% CAGR over FY08-14E.

Emkay recommends `Buy` on Bajaj Auto

Emkay has recommended ` Buy` on Bajaj Auto with a price target of Rs 1,650 as against the current market price (CMP) of Rs 1,460 in its report dated Apr.1, 2011.

Emkay recommends `Buy` on Coromandel Intl

Emkay has recommended ` Buy ` on Coromandel International with a price target of Rs 435 as against the current market price (CMP) of Rs 286 in its report dated Apr.1, 2011. The broking house gave the following rationale: > CIL has presence in Di-Ammonium Phosphate (DAP) and complex fertilisers and commands approx 15% market share. It also has presence in the non fertiliser business which includes agrochemicals, specialty fertilisers, micro nutrients, compost etc and contributes approximately 10% to revenues

Emkay maintains `Buy` on Phoenix Mills

Emkay has recommended `Buy` on Phoenix Mills with a price target of Rs 231 as against the current market price (CMP) of Rs 182 in its report dated Apr.

Greshma Shares maintains `Buy` on MSP Steel & Power

Greshma

KR Choksey maintains `Buy` on Glenmark

KR Choksey has recommended ` Buy ` on Glenmark Pharma with a price target of Rs 379 as against the current market price (CMP) of Rs 275 in its report dated Mar. 29, 2011.

Sunidhi Sec maintains `Buy` on Gitanjali Gems

Sunidhi Securities has recommended `Buy` on Gitanjali Gems with a price target of Rs 300 as against the current market price (CMP) of Rs 235 in its report dated Mar. 28, 2011. The broking house gave the following rationale: With an aim of further integration within the jewellery value chain and to diversify its business model leveraging the key strengths GGL is right on track to realize its goals.

F&O Outlook: Nifty likely to face strong support at 5,600-5,620

“On the lower side Nifty is likely to face strong support in the vicinity of 5,650-5,680 level, the level (5,700) which consists of the third highest OI (i.e. 70.89 lacs shares) among the Nifty MAR put options. On the other hand on the higher side Nifty is likely to face strong resistance in the vicinity of 5,800-5,820 level, the level (5,800 which consists of the highest in OI (i.e.